These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9382011)

  • 21. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
    Worm D; Henriksen JE; Vaag A; Thye-Rønn P; Melander A; Beck-Nielsen H
    J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
    Yki-Järvinen H; Taskinen MR
    Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus.
    Akanji AO; Osifo E; Kirk M; Hockaday TD
    Metabolism; 1993 Apr; 42(4):426-34. PubMed ID: 8487664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
    Laws A; Hoen HM; Selby JV; Saad MF; Haffner SM; Howard BV
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):64-71. PubMed ID: 9012639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between the metabolic syndrome and free fatty acid].
    Liu J; Zhao D; Liu J; Liu S; Qin LP; Wu ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):653-7. PubMed ID: 16080819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
    Reinehr T; Kiess W; Andler W
    Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships of plasma leptin levels to changes in plasma free fatty acids in women who are lean and women who are abdominally obese.
    Hennes MM; Dua A; Maas DL; Sonnenberg GE; Krakower GR; Kissebah AH
    Obes Res; 1997 Sep; 5(5):442-6. PubMed ID: 9385619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha.
    Paolisso G; Rizzo MR; Mazziotti G; Tagliamonte MR; Gambardella A; Rotondi M; Carella C; Giugliano D; Varricchio M; D'Onofrio F
    Am J Physiol; 1998 Aug; 275(2):E294-9. PubMed ID: 9688632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.
    Pirro M; Mauriège P; Tchernof A; Cantin B; Dagenais GR; Després JP; Lamarche B
    Atherosclerosis; 2002 Feb; 160(2):377-84. PubMed ID: 11849661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sequence variation in the mitochondrial glycerol-3-phosphate dehydrogenase gene is associated with increased plasma glycerol and free fatty acid concentrations among French Canadians.
    St-Pierre J; Vohl MC; Brisson D; Perron P; Després JP; Hudson TJ; Gaudet D
    Mol Genet Metab; 2001 Mar; 72(3):209-17. PubMed ID: 11243726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change and correlated factors of fasting level of the plasma endotoxin in subjects with different glucose tolerances and body mass indices].
    Liu YH; Zhao TY; Hou LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):769-73, 778. PubMed ID: 24325109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters.
    Lewis GF; Naples M; Uffelman K; Leung N; Szeto L; Adeli K
    Endocrinology; 2004 Nov; 145(11):5006-12. PubMed ID: 15271878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study.
    Pankow JS; Duncan BB; Schmidt MI; Ballantyne CM; Couper DJ; Hoogeveen RC; Golden SH;
    Diabetes Care; 2004 Jan; 27(1):77-82. PubMed ID: 14693970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients.
    Avogaro A; Crepaldi C; Miola M; Maran A; Pengo V; Tiengo A; Del Prato S
    J Endocrinol Invest; 1996 Feb; 19(2):99-105. PubMed ID: 8778173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels.
    Peinò R; Fernández Alvarez J; Peñalva A; Considine RV; Rodriguez-Segade S; Rodriguez-Garcia J; Cordido F; Casanueva FF; Dieguez C
    J Endocrinol Invest; 1998 Sep; 21(8):526-30. PubMed ID: 9801994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.